Literature DB >> 28580688

T-cell regulation through a basic suppressive mechanism targeting low-density lipoprotein receptor-related protein 1.

Jeneen Panezai1,2, Eva Bergdahl3, Karl-Gösta Sundqvist3.   

Abstract

Cell adhesion is generally considered to depend on positive regulation through ligation of integrins and cytokine receptors. However, here we show that T-cell adhesion, and notably also T-cell receptor (TCR) -induced activation, are subject to constant suppression through shedding of low-density lipoprotein receptor-related protein 1 (LRP1). The broad-spectrum metalloprotease inhibitor GM6001 abrogated shedding, so inducing prominent cell surface expression of LRP1 while enhancing TCR-induced activation and adhesion to β1 and β2 integrin ligands, hence arresting the cells. Integrin ligands also inhibited shedding but the effect was less potent than that of GM6001. Unlike GM6001, integrin ligands also induced cell surface expression of full-length thrombospondin-1 (TSP170) and TSP130, which associated with LRP1, and TSP110, which did not associate with LRP1. Cell surface expression of LRP1 and TSP130 were induced exclusively in adhering cells, expression of TSP110 preferentially in non-adhering cells and expression of TSP170 correlated with T-cell motility. The pro-adhesive chemokine CXCL12 also inhibited LRP1 shedding and induced surface expression of TSP170 and TSP130 while inhibiting TSP110. Exogenous TSP-1 and ligation of CD28 inhibited shedding although less effectively than GM6001, and the inhibition through CD28 was independent of TSP-1. Small interfering RNA silencing experiments confirmed involvement of LRP1 and TSP-1 in integrin-dependent adhesion and TCR-induced activation. Hence, the poor LRP1 expression in T cells depends on shedding. Integrin ligands and CXCL12 antagonize shedding through a TSP-1-dependent pathway and ligation of CD28 antagonizes shedding independent of TSP-1. The disappearance of LRP1 from the cell surface may provide basic immunosuppression at the T-cell level.
© 2017 John Wiley & Sons Ltd.

Entities:  

Keywords:  T-cell regulation; adhesion; motility T-cell activation

Mesh:

Substances:

Year:  2017        PMID: 28580688      PMCID: PMC5588768          DOI: 10.1111/imm.12770

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  52 in total

1.  T-cell priming by dendritic cells in lymph nodes occurs in three distinct phases.

Authors:  Thorsten R Mempel; Sarah E Henrickson; Ulrich H Von Andrian
Journal:  Nature       Date:  2004-01-08       Impact factor: 49.962

2.  Distinct T cell dynamics in lymph nodes during the induction of tolerance and immunity.

Authors:  Stéphanie Hugues; Luc Fetler; Laura Bonifaz; Julie Helft; François Amblard; Sebastian Amigorena
Journal:  Nat Immunol       Date:  2004-10-31       Impact factor: 25.606

Review 3.  Memory versus naive T-cell migration.

Authors:  Marie Lewis; John F Tarlton; Stephen Cose
Journal:  Immunol Cell Biol       Date:  2007-11-13       Impact factor: 5.126

4.  The anti-adhesive activity of thrombospondin is mediated by the N-terminal domain of cell surface calreticulin.

Authors:  Silvia Goicoechea; Manuel Antonio Pallero; Paul Eggleton; Marek Michalak; Joanne E Murphy-Ullrich
Journal:  J Biol Chem       Date:  2002-07-29       Impact factor: 5.157

5.  ADAMs 10 and 17 represent differentially regulated components of a general shedding machinery for membrane proteins such as transforming growth factor alpha, L-selectin, and tumor necrosis factor alpha.

Authors:  Sylvain M Le Gall; Pierre Bobé; Karina Reiss; Keisuke Horiuchi; Xiao-Da Niu; Daniel Lundell; David R Gibb; Daniel Conrad; Paul Saftig; Carl P Blobel
Journal:  Mol Biol Cell       Date:  2009-01-21       Impact factor: 4.138

6.  Thrombospondin signaling through the calreticulin/LDL receptor-related protein co-complex stimulates random and directed cell migration.

Authors:  A Wayne Orr; Carrie A Elzie; Dennis F Kucik; Joanne E Murphy-Ullrich
Journal:  J Cell Sci       Date:  2003-07-15       Impact factor: 5.285

7.  Chemokines and the signaling modules regulating integrin affinity.

Authors:  Alessio Montresor; Lara Toffali; Gabriela Constantin; Carlo Laudanna
Journal:  Front Immunol       Date:  2012-05-25       Impact factor: 7.561

8.  CD47-independent effects mediated by the TSP-derived 4N1K peptide.

Authors:  Pascal Leclair; Chinten James Lim
Journal:  PLoS One       Date:  2014-05-21       Impact factor: 3.240

9.  Interactions between PD-1 and PD-L1 promote tolerance by blocking the TCR-induced stop signal.

Authors:  Brian T Fife; Kristen E Pauken; Todd N Eagar; Takashi Obu; Jenny Wu; Qizhi Tang; Miyuki Azuma; Matthew F Krummel; Jeffrey A Bluestone
Journal:  Nat Immunol       Date:  2009-09-27       Impact factor: 25.606

10.  Integrin-modulating therapy prevents fibrosis and autoimmunity in mouse models of scleroderma.

Authors:  Elizabeth E Gerber; Elena M Gallo; Stefani C Fontana; Elaine C Davis; Fredrick M Wigley; David L Huso; Harry C Dietz
Journal:  Nature       Date:  2013-10-09       Impact factor: 49.962

View more
  5 in total

Review 1.  The role of lipid metabolism in shaping the expansion and the function of regulatory T cells.

Authors:  Alessandra Pinzon Grimaldos; Simone Bini; Ilenia Pacella; Alessandra Rossi; Alessia Di Costanzo; Ilenia Minicocci; Laura D'Erasmo; Marcello Arca; Silvia Piconese
Journal:  Clin Exp Immunol       Date:  2022-06-11       Impact factor: 5.732

2.  CD28 Superagonist Shock and Blockage of Motogenic T Cell Cascade.

Authors:  Karl-Gösta Sundqvist
Journal:  Front Immunol       Date:  2021-04-21       Impact factor: 7.561

3.  Identification of an Immune-Related Risk Signature Correlates With Immunophenotype and Predicts Anti-PD-L1 Efficacy of Urothelial Cancer.

Authors:  Pengju Li; Shihui Hao; Yongkang Ye; Jinhuan Wei; Yiming Tang; Lei Tan; Zhuangyao Liao; Mingxiao Zhang; Jiaying Li; Chengpeng Gui; Jiefei Xiao; Yong Huang; Xu Chen; Jiazheng Cao; Junhang Luo; Wei Chen
Journal:  Front Cell Dev Biol       Date:  2021-03-18

4.  T Cell Motility─How Is It Regulated?

Authors:  Karl-Gösta Sundqvist
Journal:  Front Immunol       Date:  2020-12-11       Impact factor: 7.561

5.  T Cell Co-Stimulation: Inhibition of Immunosuppression?

Authors:  Karl-Gösta Sundqvist
Journal:  Front Immunol       Date:  2018-05-03       Impact factor: 7.561

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.